Cargando…
Open Peer Commentary to “Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE Trials as reported by Biogen December 2019”
Autores principales: | Sabbagh, Marwan Noel, Cummings, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043968/ https://www.ncbi.nlm.nih.gov/pubmed/33135288 http://dx.doi.org/10.1002/alz.12235 |
Ejemplares similares
-
ENGAGE and EMERGE: Truth and consequences?
por: Kuller, Lewis H., et al.
Publicado: (2021) -
Building an evidence base for stakeholder engagement
por: Lavery, James V.
Publicado: (2018) -
China's Engagement with Global Health Diplomacy: Was SARS a Watershed?
por: Chan, Lai-Ha, et al.
Publicado: (2010) -
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
por: Cummings, Jeffrey, et al.
Publicado: (2021) -
Grand Challenges in Global Health: Community Engagement in Research in Developing Countries
por: Tindana, Paulina O, et al.
Publicado: (2007)